Notably, most DAMPs or MAMPs mediate the cross-presentation of tumor antigens to CD8+ cytotoxic T lymphocytes (CTLs) through pattern recognition receptors (PRRs) on APCs, including dendritic cells (DCs), macrophages, and other components of the innate immune system, ultimately promoting the recognition and elimination of cancer cells12. This evidence concerns the gene CD8A and cancer.